Skip to content

Comparing the effectiveness of treatment for obsessive-compulsive disorder

Comparison of the effectiveness of Danger Ideation Reduction Therapy with Exposure and Response Prevention and drug treatment in obsessive-compulsive disorder

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240523061876N1
Enrollment
30
Registered
2025-10-29
Start date
2025-08-06
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder.

Interventions

Intervention 1: Intervention group: Intervention group: The content of the sessions will be conducted over 10 sessions (one 45-minute session per week). DIRT components include six separate therapeuti

Sponsors

Artesh University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Diagnosis of obsessive-compulsive disorder

Exclusion criteria

Exclusion criteria: thoughts or attempting suicide

Design outcomes

Primary

MeasureTime frame
Severity Obsession. Timepoint: Before and after treatment. Method of measurement: Yale-Brown Obsessive-Compulsive Scale(Y-BOCS-II).;Depression. Timepoint: Before and after treatment. Method of measurement: Depression Anxiety Stress Scale(DASS-21).;Anxiety. Timepoint: Before and after treatment. Method of measurement: Depression Anxiety Stress Scale(DASS-21).;Client Engagement. Timepoint: Before and after treatment. Method of measurement: Client Engagement Scale(CES).;Psychological Wellbeing. Timepoint: Before and after treatment. Method of measurement: Ryff Scale Psychological Wellbeing(RSPWB).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPyruz Rezaei

Artesh University of Medical Sciences

pyruzr@yahoo.com+98 21 2248 1806

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026